Weng Shuting, Zuo Jingye, Mo Jiali, Ye Leping
Department of Pediatric Pulmonology, Children's Medical Center, Peking University First Hospital, Beijing, China.
Front Immunol. 2025 Jun 10;16:1557848. doi: 10.3389/fimmu.2025.1557848. eCollection 2025.
Idiopathic pulmonary fibrosis (IPF) is a progressive lung disease characterized by irreversible lung tissue scarring. Cellular senescence (CS) plays a significant role in IPF pathogenesis, yet the specific molecular mechanisms remain unclear. This study aimed to identify key CS-related differentially expressed genes (CS-DEGs) and investigate their potential as diagnostic biomarkers and therapeutic targets for IPF.
Bioinformatics analysis was conducted on the GSE53845 dataset to identify CS-DEGs in IPF. Gene set enrichment analysis (GSEA), protein-protein interaction (PPI) network analysis, and functional enrichment analyses were performed to explore the biological functions and pathways associated with CS-DEGs. External validation of the identified CS-DEGs was performed using two independent datasets, GSE32537 and GSE24206. Immunofluorescence staining on lung tissue samples from IPF patients and normal controls was performed to validate the expression of key CS-DEGs.
A total of 122 DEGs were identified, and 8 core CS-DEGs were selected. CDKN2A, VEGFA, SOX2, and FOXO3 were validated as key CS-DEGs, with high diagnostic potential for IPF. Functional enrichment analysis revealed their involvement in critical biological pathways, including cellular senescence, immune response, and fibrosis regulation. Immunofluorescence staining confirmed higher expression of CDKN2A and SOX2, and lower expression of FOXO3 and VEGFA in IPF lung tissues compared to normal controls.
This study highlights the significant role of CS-related genes in the pathogenesis of IPF and identifies four key CS-DEGs (CDKN2A, SOX2, FOXO3, and VEGFA) that could serve as potential biomarkers and therapeutic targets for IPF, providing a basis for further research.
特发性肺纤维化(IPF)是一种以不可逆的肺组织瘢痕形成为特征的进行性肺部疾病。细胞衰老(CS)在IPF发病机制中起重要作用,但其具体分子机制仍不清楚。本研究旨在鉴定关键的CS相关差异表达基因(CS-DEGs),并研究它们作为IPF诊断生物标志物和治疗靶点的潜力。
对GSE53845数据集进行生物信息学分析,以鉴定IPF中的CS-DEGs。进行基因集富集分析(GSEA)、蛋白质-蛋白质相互作用(PPI)网络分析和功能富集分析,以探索与CS-DEGs相关的生物学功能和途径。使用两个独立数据集GSE32537和GSE24206对鉴定出的CS-DEGs进行外部验证。对IPF患者和正常对照的肺组织样本进行免疫荧光染色,以验证关键CS-DEGs的表达。
共鉴定出122个DEGs,并选择了8个核心CS-DEGs。CDKN2A、VEGFA、SOX2和FOXO3被验证为关键的CS-DEGs,对IPF具有较高的诊断潜力。功能富集分析揭示它们参与关键生物学途径,包括细胞衰老、免疫反应和纤维化调节。免疫荧光染色证实,与正常对照相比,IPF肺组织中CDKN2A和SOX2表达较高,而FOXO3和VEGFA表达较低。
本研究突出了CS相关基因在IPF发病机制中的重要作用,并鉴定出四个关键的CS-DEGs(CDKN2A、SOX2、FOXO3和VEGFA),它们可作为IPF的潜在生物标志物和治疗靶点,为进一步研究提供了基础。